AMLs harboring DNMT3A-destabilizing variants show increased intratumor DNA methylation heterogeneity at bivalent chromatin domains
D. Lee, B. Koo, S.-H. Kim, J. Byun, J. Hong, D.-Y. Shin, C.-H. Sun, J.-J. Song, J. Kim, S. Jaiswal, S.-s. Yoon, S. Kim, Y. Koh
This study shows that DNMT3A-destabilizing mutations in AML increase DNA methylation heterogeneity at bivalent chromatin domains, affecting leukemic stem cell-niche interactions and drug response.
bioRxiv · Feb 13, 2023 · PreprintCancer Biology